Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

Shweta Maniar, global director, life sciences strategy & solutions for Google Cloud, recently discussed with GEN Edge the survey and the broader challenges faced by life sciences and healthcare users ...

Researchers say the deep learning model may help to create leads for new cancer diagnostics, patient stratification, and future therapies.

CEPI will work with Samsung Biologics to establish a scalable, rapid manufacturing process for recombinant-protein vaccines.

HIEs were used to identify why the growth of norovirus in culture stops and to determine methods to maintain growth.